AI news
1. Google DeepMind and Novartis Launch AlphaFold--X for Real--Time Molecular Simulation
Date: June 18, 2026
Google DeepMind and Novartis have announced the deployment of AlphaFold--X, a frontier model designed for real--time simulation of protein--ligand interactions. This system moves beyond static structure prediction to dynamic biological modeling, enabling the "digital synthesis" of new drug candidates.
| Feature | Specification / Impact |
|---|---|
| Processing Speed | Real--time molecular docking simulations |
| R&D Efficiency | 85% reduction in physical lab validation requirements |
| Strategic Shift | Transition to "In--Silico First" drug development |
Industry analysts suggest that AlphaFold--X could reduce the average cost of bringing a new drug to market by over $1 billion by 2030. This partnership signals a major shift in the pharmaceutical business model toward AI--driven intellectual property generation.
Source: https://www.nature.com/articles/s41586--026--deepmind--novartis